Plaisance

Plaisance is a biotechnology company focused on the development of novel therapies for dermatological and immunological conditions. The company was founded by experienced biopharmaceutical executives, including Dr. Lynn Seely, with a mission to address significant unmet needs in skin health. Plaisance's lead programs leverage advanced small molecule chemistry to target inflammatory pathways, specifically focusing on next-generation inhibitors for chronic skin diseases. By utilizing a lean, asset-centric model, the company aims to rapidly advance its candidates through early-stage clinical development to provide improved treatment options for patients suffering from conditions like atopic dermatitis.